cystamine has been researched along with cytochrome c-t in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kim, IY; Kim, TS; Yun, BY | 1 |
Chen, TY; Chiang, SY; Hsu, TC; Kao, SH; Kuo, CY; Li, SL; Tzang, BS | 1 |
2 other study(ies) available for cystamine and cytochrome c-t
Article | Year |
---|---|
Induction of the mitochondrial permeability transition by selenium compounds mediated by oxidation of the protein thiol groups and generation of the superoxide.
Topics: Cystamine; Cystine; Cytochromes c; Humans; Mitochondria; Mitochondrial Swelling; Organoselenium Compounds; Oxidation-Reduction; Permeability; Selenium; Selenomethionine; Sodium Selenite; Sulfhydryl Compounds; Superoxides | 2003 |
Cystamine attenuates lupus-associated apoptosis of ventricular tissue by suppressing both intrinsic and extrinsic pathways.
Topics: Animals; Apoptosis; Apoptotic Protease-Activating Factor 1; bcl-Associated Death Protein; BH3 Interacting Domain Death Agonist Protein; Caspase 3; Caspase 8; Caspase 9; Cystamine; Cytochromes c; fas Receptor; Heart Ventricles; Immunoblotting; In Situ Nick-End Labeling; Lupus Erythematosus, Systemic; Male; Mice; Mice, Inbred BALB C; Mice, Inbred NZB; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2 | 2012 |